Results 101 to 110 of about 13,648 (298)

Medical management of inflammatory bowel disease [PDF]

open access: yes, 1999
Patients who have recently been diagnosed as suffering from inflammatory bowel disease face two disturbing realities: firstly the true cause of the disease has not yet been defined and secondly the long term prognosis is unpredictable.
Pullicino, Edgar
core  

Clinical and pathologic remission of pediatric ulcerative colitis with serum-derived bovine immunoglobulin added to the standard treatment regimen [PDF]

open access: yes, 2017
Ulcerative colitis (UC) is a chronic inflammatory bowel disease that is particularly troublesome for pediatric patients, as current therapeutic options consist of biologic agents and steroids which alter the immune response and have the harmful side ...
Ramos-Soriano, Asuncion G.   +1 more
core   +2 more sources

Anti‐Inflammatory Peptides as Promising Therapeutics Agent Against Inflammatory Bowel Diseases: A Systematic Review

open access: yesJGH Open, Volume 9, Issue 7, July 2025.
ABSTRACT Background Inflammatory bowel disease (IBD) is linked to dysregulated mucosal immunity, microbiota imbalances, and environmental factors, though its exact cause remains unknown. Current treatments often have limitations, necessitating innovative therapies.
Kiarash Ghazvini   +5 more
wiley   +1 more source

Patient considerations in the management of ulcerative colitis: role of once-daily MMX mesalamine

open access: yesPatient Preference and Adherence, 2009
Daniel B Zandman, Mark A PeppercornHarvard Medical School, Division of Gastroenterology, Department of Medicine, Beth Israel Deaconess Medical Center, Boston, MA, USAAbstract: Mesalamine and its derivatives are effective and well-tolerated therapies for ...
Daniel B Zandman, Mark A Peppercorn
doaj  

Increased Fiber Intake Enhances Clostridia Bacteria and Reduces Clinical Relapse in Patients With Clinically Quiescent Inflammatory Bowel Disease: A Prospective Longitudinal Study

open access: yesJGH Open, Volume 9, Issue 7, July 2025.
ABSTRACT Background and Aim A high‐fiber, low‐animal‐protein, and low‐saturated‐fat diet may modulate gut dysbiosis and benefit inflammatory bowel disease (IBD). This study investigated the effects of this diet on clinical relapses, fecal calprotectin, and gut microbiota in patients with clinically quiescent IBD.
Julajak Limsrivilai   +11 more
wiley   +1 more source

Proof-of-concept for Site-specific Delivery of Mesalamine Nanoparticles for Effective Therapy in Colitis

open access: yes, 2021
Background: Mesalamine loaded polymeric nanoparticles were prepared using three different polymers namely, Eudragit RS100, PLGA (50:50), or Eudragit RLPO, with an aim of targeted delivery to the inflamed colon.
N. Sreeharsha   +3 more
semanticscholar   +1 more source

Determination of Mesalamine Related Impurities from Drug Product by Reversed Phase Validated UPLC Method

open access: yesE-Journal of Chemistry, 2011
In the present study gradient reversed-phase UPLC method was developed for simultaneous determination and separation of impurities and degradation products from drug product.
Trivedi Rakshit Kanubhai   +2 more
doaj   +1 more source

Simple and sensitive spectrophotometric methods for the analysis of mesalamine in bulk and tablet dosage forms

open access: yesQuímica Nova, 2011
Three simple, sensitive, economical and reproducible spectrophotometric methods (A, B and C) are described for determination of mesalamine in pure drug as well as in tablet dosage forms. Method A is based on the reduction of tungstate and/or molybdate in
Bala Sekaran Chandra   +5 more
doaj   +1 more source

Oral adjuvant curcumin therapy for attaining clinical remission in ulcerative colitis: A systematic review and meta-analysis of randomized controlled trials [PDF]

open access: yes, 2018
Curcumin has demonstrated anti-inflammatory properties and has been investigated as an adjuvant therapy of ulcerative colitis (UC). The scope of this study was to systematically review and meta-analyze the efficacy of oral curcumin administration as an ...
Asteriou, Eleni   +5 more
core   +1 more source

Defining normal bowel wall thickness in children with inflammatory bowel disease in deep remission: A multicenter study on behalf of the pediatric committee of the International Bowel Ultrasound Group (IBUS)

open access: yesJournal of Pediatric Gastroenterology and Nutrition, Volume 81, Issue 1, Page 53-61, July 2025.
Abstract Objectives Intestinal ultrasound (IUS) is a noninvasive tool for detecting and monitoring disease activity in children with inflammatory bowel disease (IBD). Remission values for bowel wall thickness (BWT) are extrapolated from adult data. We aimed to define normal BWT in children with IBD in sustained deep remission.
Amelia Kellar   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy